Introduction: Who Should Undergo Diagnostics and When

Gestational diabetes diagnostics are an important part of prenatal care for all pregnant women. If you’re pregnant, your healthcare provider will check you for gestational diabetes as part of your routine prenatal appointments. This screening is not because something is wrong, but because gestational diabetes often develops without obvious symptoms that you can easily notice^[1].

Most healthcare providers recommend that all pregnant women undergo screening for gestational diabetes during the second trimester, typically between 24 and 28 weeks of pregnancy. This timing is chosen because gestational diabetes usually appears during the middle of pregnancy, when hormones from the placenta (the organ that nourishes your baby) start to interfere more strongly with how your body processes sugar^[4].

However, some women may need to be tested earlier in their pregnancy. If you’re at higher risk for developing gestational diabetes, your healthcare provider might order screening tests during your first prenatal visit, which typically happens around 8 to 12 weeks of pregnancy. Even if this early test comes back normal, you’ll likely be tested again at the standard 24 to 28 week timeframe^[6].

You should seek healthcare early in your pregnancy planning, ideally when you’re thinking about trying to get pregnant. At that time, your healthcare professional can check your overall risk of gestational diabetes and your general wellness. This early assessment helps identify whether you’ll need closer monitoring during pregnancy^[1].

Certain factors put you at increased risk of developing gestational diabetes. You’re at higher risk if you’re over 40 years old, if your body mass index (BMI, a measure of body weight relative to height) is above 30, if you previously had a baby who weighed more than 4.5 kilograms (about 10 pounds) at birth, or if you had gestational diabetes in a previous pregnancy. Your risk is also increased if one of your parents or siblings has diabetes, if you’re of South Asian, Black, African-Caribbean, or Middle Eastern origin (even if you were born in the United Kingdom or United States), or if you’ve had weight-loss surgery such as gastric bypass^[6].

Additional risk factors include having polycystic ovary syndrome (PCOS, a hormone disorder that affects the ovaries), having high blood pressure or heart disease, or being pregnant with twins or multiples. Gestational diabetes is two to three times more common in twin and multiple pregnancies because you typically have multiple placentas or a larger placenta, which produces more hormones that can interfere with insulin^[3][7].

Diagnostic Methods Used to Identify Gestational Diabetes

The main way to diagnose gestational diabetes is through blood sugar testing. Your healthcare provider will use specific screening tests that measure how your body handles glucose (sugar) during pregnancy. These tests are designed to identify women whose blood sugar levels are higher than normal but who may not have any noticeable symptoms^[9].

The Initial Glucose Challenge Test

The screening process typically begins with what’s called a glucose challenge test. For this test, you’ll drink a sweet liquid that contains a specific amount of glucose. This syrupy solution is designed to raise your blood sugar in a controlled way. One hour after you drink the solution, a healthcare professional will take a blood sample to measure your blood sugar level^[9].

The glucose challenge test is meant to identify women who might have gestational diabetes and need further testing. You don’t need to fast or avoid eating before this test, which makes it convenient. During the one-hour waiting period, you’ll need to stay relatively still and avoid walking around, as physical activity can lower your blood sugar levels and affect the test results^[7].

If your blood sugar level measured during this test is below 140 milligrams per deciliter (mg/dL), or 7.8 millimoles per liter (mmol/L), this is usually considered within the normal range. However, if your result is 190 mg/dL (10.6 mmol/L) or higher, this indicates you have gestational diabetes, and no further testing is needed to confirm the diagnosis. If your blood sugar level falls between these two values—higher than normal but not definitively diagnostic—you’ll need a follow-up test to determine whether you have gestational diabetes^[9].

The Oral Glucose Tolerance Test

When the initial glucose challenge test suggests possible gestational diabetes, your healthcare provider will order a more detailed test called an oral glucose tolerance test (OGTT). This test takes about two hours and provides more comprehensive information about how your body processes glucose^[6].

For the OGTT, you’ll need to prepare by not eating or drinking anything (except water) for 8 to 10 hours before the test. It’s important to check with the hospital about whether you can drink water during this fasting period. The test begins in the morning with a blood sample taken while you’re still fasting. This first sample measures your baseline blood sugar level before you consume any glucose^[6].

After this initial blood test, you’ll drink a glucose solution that contains even more sugar than the first screening test. Then you’ll rest for two hours while your body processes the glucose. During this waiting period, it’s important to remain seated and avoid physical activity, as movement can affect your blood sugar levels. After the two hours have passed, another blood sample is taken to see how well your body handled the glucose^[6].

Some healthcare facilities may take multiple blood samples during the OGTT—at one hour, two hours, and three hours after you drink the glucose solution. If two or more of these blood sugar readings are higher than expected, this confirms a diagnosis of gestational diabetes^[9].

Understanding Your Test Results

Different healthcare organizations around the world use slightly different criteria to diagnose gestational diabetes, which is why your specific numbers may vary depending on where you receive care. However, the basic principle remains the same: the tests measure whether your blood sugar rises too high after consuming glucose and whether your body can bring those levels back down to normal^[8].

The diagnosis of gestational diabetes has evolved over several decades as researchers have learned more about how maternal blood sugar levels affect pregnancy outcomes. The criteria used today are based on evidence showing that certain blood sugar levels during pregnancy increase the risk of complications for both mother and baby^[8].

It’s worth understanding that gestational diabetes is different from type 1 diabetes and type 2 diabetes. Type 1 diabetes is an autoimmune condition where the body doesn’t produce insulin, while type 2 diabetes develops when the body can’t use insulin effectively over many years. Gestational diabetes, on the other hand, develops specifically because of pregnancy and typically goes away after the baby is born. Women who had type 1 or type 2 diabetes before becoming pregnant face different challenges and management needs than women who develop gestational diabetes^[3].

Why Timing of Testing Matters

The timing of gestational diabetes screening is carefully chosen based on how pregnancy affects your body’s insulin function. During pregnancy, your body naturally becomes more resistant to insulin, especially in the second half of pregnancy. This insulin resistance (when your cells don’t respond as well to insulin) is a normal part of pregnancy that ensures your baby gets enough nutrients. However, in some women, this insulin resistance becomes too severe, leading to gestational diabetes^[2].

The 24 to 28 week timeframe for screening is chosen because this is when pregnancy hormones are strong enough to reveal whether a woman’s body can produce enough insulin to overcome the increased resistance. Testing earlier might miss some cases because insulin resistance hasn’t fully developed yet, while testing later delays diagnosis and treatment^[4].

Diagnostics for Clinical Trial Qualification

When women with gestational diabetes participate in clinical trials, researchers use specific diagnostic criteria to determine who can join the study. These criteria help ensure that the trial participants truly have gestational diabetes and that the study results will be meaningful and applicable to similar patients^[8].

Clinical trials testing treatments for gestational diabetes typically require participants to have been diagnosed using standardized blood sugar testing methods. The most common approach is the oral glucose tolerance test, which provides clear, measurable data about how a woman’s body processes glucose. Researchers need this objective diagnostic information to establish a baseline for each participant before any treatment begins^[8].

The timing of diagnosis also matters for clinical trial enrollment. Most trials want to include women who are diagnosed during the typical screening window of 24 to 28 weeks of pregnancy. This timing is important because it allows enough time during pregnancy to test whether a treatment is effective while still leaving time to see outcomes before the baby is born^[8].

Clinical trials may divide participants into different categories based on the severity of their gestational diabetes. Some women can control their blood sugar levels through diet and exercise alone—this is sometimes called class A1 gestational diabetes. Other women need medication, such as insulin injections or tablets like metformin, to keep their blood sugar in a healthy range—this is called class A2 gestational diabetes. Researchers often want to study these groups separately because they may respond differently to new treatments^[8].

Before entering a clinical trial, potential participants undergo thorough diagnostic testing to confirm their gestational diabetes diagnosis and to rule out other conditions. This testing also helps researchers understand each woman’s specific situation, including her blood sugar patterns, any risk factors she has, and any other health conditions that might affect the trial results^[8].

Clinical trials may also use home blood sugar monitoring as part of their diagnostic and monitoring process. Participants might be asked to test their blood sugar levels multiple times a day using a finger-prick device and testing strips. This provides detailed information about how blood sugar levels change throughout the day in response to meals, physical activity, and any treatments being tested. Some trials may provide continuous glucose monitors (CGMs), which are small sensors worn on the skin that automatically track blood sugar levels and send the data wirelessly to a receiver or smartphone^[17].

The diagnostic criteria used in clinical trials must be consistent with established medical guidelines, but trials may have additional requirements. For example, a trial might only include women whose fasting blood sugar is above a certain level, or who require insulin treatment, or who have specific risk factors like obesity or a family history of type 2 diabetes. These specific criteria help researchers answer particular questions about how different groups of women respond to treatments^[8].